Non-Invasive Glucose Monitoring Patent Landscape Report and Forecast 2024-2032

Non-Invasive Glucose Monitoring Patent Landscape Report and Forecast 2024-2032

ms, suction or irrigation systems, closure devices, hand instruments, access devices, and accessories. Among these, robot-assisted surgical systems lead the patent landscape with over 2,000 patents granted historically and more than 300 new filings in the last year. Their leadership is driven by innovations in robotic precision and AI-enhanced navigation. Future growth is expected as advancements focus on improving control and integration with surgical workflows.

Analysis by Application

• General Surgery
• Cholecystectomies
• Hernia Repairs
• Appendectomies
• Antireflux Surgeries
• Other General Surgery
• Bariatric Surgery
• Gastric Bypass
• Sleeve Gastrectomy
• Gastric Banding
• Other Bariatric Surgery
• Gynecological Surgery
• Urological Surgery
• Colorectal Surgery

The patent segmentation by application includes general surgery, bariatric surgery, gynaecological surgery, urological surgery, and colorectal surgery. Within general surgery, cholecystectomies dominate the patent landscape with over 1,500 patents historically and more than 200 new filings recently. This dominance is due to innovations in minimally invasive techniques and improved patient safety. Future growth is anticipated as advancements target enhanced surgical efficiency and outcomes.

Analysis by End User

• Hospital
• Ambulatory Surgical Centre

The patent segmentation by end user includes hospitals and ambulatory surgical centres. Hospitals lead the patent landscape with over 2,500 patents historically and more than 400 new filings in the last year. This dominance is due to innovations in integrated surgical systems and enhanced patient care. Future growth is expected as advancements focus on workflow optimisation and telemedicine capabilities, reinforcing hospitals' leadership in the patent landscape.

Laparoscopy Devices Patent Jurisdiction Analysis

The global patent landscape for laparoscopy devices is characterised by significant activity across key regions, including the United States, Europe, and Asia Pacific. In the United States, over 3,500 patents have been filed, driven by major companies' focus on integrating advanced robotic technologies and AI systems. In Europe, particularly in Germany and the UK, over 2,500 patents emphasise innovations in surgical precision and device interoperability, influenced by stringent regulatory standards. The Asia Pacific region, notably China and Japan, has filed over 2,000 patents, reflecting a dynamic and expanding healthcare technology landscape, with an emphasis on cost-effective and scalable solutions.

Patent Profile of Key Companies

The patent landscape for laparoscopy devices is shaped by several key companies driving innovation and securing intellectual property. Here is an overview of their patent activities.

Intuitive Surgical Inc.

Intuitive Surgical Inc., headquartered in Sunnyvale, California, holds over 3,000 patents related to laparoscopy devices, with approximately 400 patents in progress. The company focuses on innovations in robotic surgical systems and AI-enhanced navigation, aiming to improve surgical precision and outcomes. Intuitive Surgical's strategic patent filings reflect its commitment to leading minimally invasive surgical technology development.

Covidien LP

Covidien LP, based in Dublin, Ireland, has filed over 2,500 patents in the laparoscopy devices sector, with around 350 patents currently in progress. The company focuses on advanced energy devices and minimally invasive techniques, improving surgical efficiency and patient safety. Covidien's innovations aim to advance surgical technology and maintain its leadership in the laparoscopy industry.

Endochoice Inc.

Endochoice Inc., located in Alpharetta, Georgia, has filed over 1,000 patents related to laparoscopy devices, with approximately 150 patents in progress. The company's focus is on developing flexible laparoscopes and innovative access devices that enhance surgical versatility and patient outcomes. Endochoice's strategic patent filings are aimed at expanding its influence in the minimally invasive surgery sector.

Other key players in the industry include Auris Health Inc. and Ethicon Endo Surgery Inc.

Key Questions Answered in the Global Laparoscopy Devices Patent Landscape Report

• What are laparoscopy devices, and how do they enhance minimally invasive surgery?
• What is the current state of the global patent landscape for laparoscopy devices?
• Which companies are leading the patent filings in the laparoscopy devices industry?
• What are the key drivers of patent activity in laparoscopy technologies?
• How do robotic-assisted surgical systems contribute to advancements in laparoscopy?
• What role does AI integration play in the development of laparoscopy devices?
• Which regions are most active in patent filings for laparoscopy devices, and why?
• How do patents for energy devices impact the laparoscopy landscape?
• What future trends are anticipated in the laparoscopy devices patent landscape?
• How do jurisdictional differences affect the patent landscape for laparoscopy devices?
• What challenges do companies face in securing patents for laparoscopy technologies?
• How do patents for hospital-focused devices differ from those for ambulatory surgical centres?
• What impact does regulatory compliance have on patent filings in the laparoscopy devices industry?
• How is the competitive landscape in the laparoscopy devices industry shaped by patent activities?

Reasons to Purchase this Report

This report offers an in-depth analysis of the patent landscape, covering key trends, technological advancements, and regional insights. It provides detailed segmentation and highlights areas of significant innovation and activity. By examining leading companies' strategies and patent portfolios, the report elucidates competitive dynamics and emerging opportunities. Stakeholders will gain valuable information for strategic decision-making, ensuring they stay ahead in the evolving industry. This comprehensive coverage makes it an essential resource for understanding the industry's future direction."
"Global Airway Management Devices Patent Landscape Report 2024

Global Airway Management Devices Industry Size

The global airway management devices market was valued at USD 2.6 billion in 2023. It is expected to grow at a CAGR of 5.9% during the forecast period of 2024-2032, reaching a market value of USD 4.3 billion by 2032. The patent landscape is driven by innovations in ergonomic designs, enhanced airway seal integrity, and real-time monitoring features, which are expected to propel the market forward and expand the adoption of airway management devices globally.

Patent Landscape Report Coverage

This report provides a comprehensive analysis of the global airway management devices patent landscape. It examines patent trends, key innovations, and emerging technologies in the field of airway management. The report covers patent filings, patent grants, and leading companies, highlighting strategic advancements and innovations shaping the future of airway management technology. It serves as an essential resource for stakeholders seeking insights into the intellectual property dynamics and competitive landscape of the airway management devices industry.

Global Airway Management Devices Patent Outlook

• The airway management devices patent landscape is driven by advancements in supraglottic airway devices, laryngoscope technologies, and smart features integration. Over 6,000 patents focus on enhancing airway seal, patient comfort, and real-time monitoring. Future growth is expected through innovations in ergonomic design and smart respiratory monitoring systems.
• Companies such as ResMed Pty Ltd and Bayer Healthcare AG are leading the patent landscape, with thousands of patents. They focus on non-invasive ventilation, smart monitoring systems, and ergonomic designs, driving innovation and maintaining leadership in airway management through strategic patent filings.
• In the United States, over 3,000 patents highlight innovations in advanced materials and smart technologies. European patents, particularly in Germany and the UK, emphasize patient safety and device efficiency, influenced by stringent regulations. The Asia Pacific region, led by China and Japan, prioritises cost-effective, scalable solutions with over 1,800 patents filed.

Airway Management Devices Introduction

Airway management devices are critical tools in healthcare, ensuring open airways for patients requiring respiratory support or during surgical procedures. These devices, including endotracheal tubes, laryngeal mask airways, and laryngoscopes, facilitate ventilation and oxygenation. The patent landscape for airway management devices reflects significant innovation driven by the need for improved patient safety, enhanced device efficiency, and integration of advanced materials and technologies.

• Patent activity in this area focuses on enhancing airway seal and patient comfort. Over 1,800 patents have been filed in the past decade, with recent filings emphasizing innovations in material composition and ergonomic designs for improved performance and ease of use.
• Laryngoscope technologies have seen a surge in patents aimed at improving visualisation and ease of intubation. Historically, around 1,200 patents have been filed, with new patents focusing on video laryngoscopes and fibre-optic enhancements to increase procedural success rates.
• The incorporation of smart features is a key patent driver, with approximately 900 patents filed focusing on real-time monitoring and feedback systems. Future innovations are expected to enhance patient safety through automated alerts and data analytics, improving overall airway management outcomes.

These drivers foster a dynamic patent landscape, promoting cutting-edge innovations in airway management technologies that enhance patient safety and care efficiency.

Global Airway Management Devices Patent Segmentation Analysis

The report provides an in-depth analysis of the patents in this field by the following segmentation:

Analysis by Type

• Infraglottic Airway Management Devices
• Endotracheal Tubes
• Tracheostomy Tubes
• Supraglottic Airway Management Devices
• Laryngeal Mask Airways
• Oropharyngeal Mask Airways
• Nasopharyngeal Mask Airways
• Others
• Laryngoscopes
• Resuscitators
• Others

The patent segmentation in the airway management devices industry includes infraglottic devices (endotracheal and tracheostomy tubes), supraglottic devices (laryngeal, oropharyngeal, and nasopharyngeal mask airways), laryngoscopes, resuscitators, and others. Among these, supraglottic airway devices lead the patent landscape with over 2,000 patents granted historically and more than 300 new filings in the last year. This dominance is driven by innovations in ergonomic design and material advancements. Future growth is expected as advancements focus on improving patient comfort and airway seal integrity.

Analysis by Application

• Anesthesia
• Emergency Medicine
• Others

The patent segmentation by application includes anaesthesia, emergency medicine, and others. Anaesthesia applications dominate the patent landscape with over 1,500 patents historically and more than 200 new filings recently. Their leadership is driven by innovations in device compatibility with anaesthetic equipment and enhanced safety features. Future growth is anticipated as advancements target real-time monitoring and improved patient safety.

Analysis by End User

• Hospitals
• Operating Rooms
• Emergency Care Departments
• Intensive Care Units
• Ambulatory Care Settings
• Home Care Settings
• Others

The patent segmentation by end-user includes hospitals, operating rooms, emergency care departments, intensive care units, ambulatory care settings, home care settings, and others. Hospitals lead the patent landscape with over 2,500 patents historically and more than 400 new filings in the last year. This dominance is due to innovations in integrated respiratory systems and improved patient care protocols. Future growth is expected as advancements focus on telemedicine integration and enhanced patient monitoring.

Airway Management Devices Patent Jurisdiction Analysis

The global patent landscape for airway management devices is characterised by significant activity across key regions, including the United States, Europe, and Asia Pacific. In the United States, over 3,000 patents have been filed, driven by major companies' focus on integrating advanced materials and smart technologies. In Europe, particularly in Germany and the UK, over 2,200 patents emphasize innovations in patient safety and device efficiency, influenced by stringent regulatory standards. The Asia Pacific region, notably China and Japan, has filed over 1,800 patents, reflecting a dynamic and expanding healthcare technology landscape, with an emphasis on cost-effective and scalable solutions.

Patent Profile of Key Companies

The patent landscape for airway management devices is shaped by several key companies driving innovation and securing intellectual property. Here is an overview of their patent activities.

ResMed Pty Ltd

ResMed Pty Ltd, headquartered in San Diego, California, holds over 1,500 patents related to airway management devices, with approximately 200 patents in progress. The company focuses on innovations in non-invasive ventilation and smart respiratory monitoring systems, aiming to enhance patient comfort and treatment efficacy. ResMed's strategic patent filings reflect its commitment to advancing respiratory care technology.

Bayer Healthcare AG

Bayer Healthcare AG, based in Leverkusen, Germany, has filed over 1,200 patents in the airway management devices sector, with around 150 patents currently in progress. The company focuses on advanced material technologies and ergonomic device designs to improve airway management outcomes. Bayer's innovations aim to enhance patient safety and maintain its leadership in healthcare technology.

Other key players in the industry include Alfen Medical Devices Dev Ltd, Alphin Medical Products Inc, and Shenzhen Yinsaidesi Medical Technology Co Ltd.

Key Questions Answered in the Global Airway Management Devices Patent Landscape Report

• What are airway management devices, and how do they enhance patient care during surgical procedures?
• What is the current state of the patent landscape for airway management devices?
• Which companies are leading the patent filings in the airway management devices industry?
• What are the key drivers of patent activity in airway management technologies?
• How do supraglottic airway devices contribute to advancements in airway management?
• What role does the integration of smart features play in the development of airway management devices?
• Which regions are most active in patent filings for airway management devices, and why?
• How do patents for laryngoscope technologies impact the airway management landscape?
• What future trends are anticipated in the airway management devices patent landscape?
• How do jurisdictional differences affect the patent landscape for airway management devices?
• What challenges do companies face in securing patents for airway management technologies?
• How do patents for hospital-focused devices differ from those for home care settings?
• What impact does regulatory compliance have on patent filings in the airway management devices industry?
• How is the competitive landscape in the airway management devices industry shaped by patent activities?

Reasons to Purchase this Report

This report offers an in-depth analysis of the patent landscape, covering key trends, technological advancements, and regional insights. It provides detailed segmentation and highlights areas of significant innovation and activity. By examining leading companies' strategies and patent portfolios, the report elucidates competitive dynamics and emerging opportunities. Stakeholders will gain valuable information for strategic decision-making, ensuring they stay ahead in the evolving landscape. This comprehensive coverage makes it an essential resource for understanding the industry's future direction."
"Global Infertility Treatment Devices Patent Landscape Report 2024

Global Infertility Treatment Devices Industry Size

The global infertility treatment devices market was valued at USD 1.2 billion in 2023. It is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032, reaching a market value of USD 2.5 billion by 2032. The global infertility treatment devices market is dynamic, with the United States leading in patent filings. It holds over 3,500 patents focused on advanced technologies, procedural efficiency, and patient safety. Approximately 600 new patents were filed in the past year, highlighting ongoing innovation. Future growth is expected to be driven by advancements in AI integration for treatment personalisation and the development of eco-friendly, cost-effective devices.

Patent Landscape Report Coverage

This report provides a comprehensive analysis of the global infertility treatment devices patent landscape. It examines patent trends, key innovations, and emerging technologies in the field of infertility treatment. The report covers patent filings, patent grants, and leading companies, highlighting strategic advancements and innovations shaping the future of infertility treatment technology. It serves as an essential resource for stakeholders seeking insights into the intellectual property dynamics and competitive landscape of the infertility treatment devices industry.

Global Infertility Treatment Devices Patent Outlook

• The infertility treatment devices industry is driven by innovations in ergonomic designs, regulatory compliance, and sustainable materials. Devices like ovum aspiration pumps and certified incubators have seen over 5,000 patents filed. These advancements enhance user comfort, procedural safety, and cost-effectiveness, propelling future industry growth.
• Leading companies, such as Guangzhou Shanshan Medical Apparatus & Instrument Industry Co Ltd and Fertility Basics Inc, have collectively filed over 2,700 patents. They focus on smart monitoring systems, automation technologies, and advanced materials to drive innovation and maintain their competitive edge in the fertility treatment landscape.
• The United States leads with over 3,500 patents, driven by technological integration and automation. Europe, with 2,300 patents, emphasizes procedural efficiency and safety due to stringent regulations. Asia Pacific, led by China and Japan, has filed over 1,900 patents, focusing on cost-effective, scalable solutions in the fertility technology sector.

Infertility Treatment Devices Introduction

Infertility treatment devices are critical tools in assisting individuals and couples to achieve successful pregnancies. These devices include sperm analyser systems, ovum aspiration pumps, and micromanipulator systems, designed to enhance the precision and success rates of fertility treatments. The patent landscape for infertility treatment devices reflects significant innovation driven by the demand for improved success rates, increased procedural efficiency, and the integration of advanced technologies and materials.

• Devices such as advanced ovum aspiration pumps are being developed with improved ergonomic designs and biocompatible materials. Over 2,000 patents have been filed focusing on enhancing user comfort and procedural safety, making these devices essential for efficient and patient-friendly fertility treatments.
• Compliance with international regulatory standards drives innovation in infertility treatment devices. Devices that meet stringent safety and efficacy standards, such as certified incubators and microscopes, have seen over 1,500 patents filed. These patents ensure the reliability and acceptance of devices across global regions, enhancing trust and adoption.
• The demand for eco-friendly and cost-effective fertility treatment solutions is leading to innovations in reusable and energy-efficient devices. Approximately 1,200 patents focus on sustainable materials and processes, driving the development of affordable treatment options that minimise environmental impact while maintaining high performance.

These drivers foster a dynamic patent landscape, promoting innovations that address patient comfort, regulatory standards, and sustainability in infertility treatments.

Global Infertility Treatment Devices Patent Segmentation Analysis

The report provides an in-depth analysis of the patents in this field by the following segmentation –

Analysis by Type

• Sperm Analyzer Systems
• Ovum Aspiration Pumps
• Sperm Separation Devices
• Micromanipulator Systems
• Imaging Systems
• Incubators
• Microscopes
• Cryo-systems
• Others

The patent segmentation in the infertility treatment devices industry includes sperm analyzer systems, ovum aspiration pumps, sperm separation devices, micromanipulator systems, imaging systems, incubators, microscopes, cryo-systems, and others. Among these, micromanipulator systems lead the patent landscape with over 2,500 patents granted historically and more than 400 new filings in the last year. This dominance is driven by innovations in automation and precision control. Future growth is expected as advancements focus on enhancing integration with other fertility technologies.

Analysis by Procedure Type

• Assisted Reproductive Technology
• Artificial Insemination
• Fertility Surgery
• Others

The patent segmentation by procedure includes assisted reproductive technology (ART), artificial insemination, fertility surgery, and others. Assisted reproductive technology dominates the patent landscape with over 1,800 patents granted historically and more than 300 new filings recently. This leadership is due to innovations aimed at improving procedural efficiency and success rates. Future growth is anticipated as advancements target personalised treatment approaches and integration with AI technologies.

Analysis by End User

• Fertility Clinics
• Hospitals and Surgical Clinics
• Research Institutes
• Others

The patent segmentation by end user includes fertility clinics, hospitals and surgical clinics, research institutes, and others. Fertility clinics lead the patent landscape with over 2,200 patents historically and more than 400 new filings in the last year. This dominance is due to innovations in specialised infertility treatment devices and protocols tailored for clinic settings, enhancing patient care and procedural success rates.

Infertility Treatment Devices Patent Jurisdiction Analysis

The global patent landscape for infertility treatment devices is characterised by significant activity across key regions, including the United States, Europe, and Asia Pacific. In the United States, over 3,500 patents have been filed, driven by major companies' focus on integrating advanced technologies and automation. In Europe, particularly in Germany and the UK, over 2,300 patents emphasize innovations in procedural efficiency and patient safety, influenced by stringent regulatory standards. The Asia Pacific region, notably China and Japan, has filed over 1,900 patents, reflecting a dynamic and expanding healthcare technology landscape, with an emphasis on cost-effective and scalable solutions.

Patent Profile of Key Companies

The patent landscape for infertility treatment devices is shaped by several key companies driving innovation and securing intellectual property. Here is an overview of their patent activities.

Guangzhou Shanshan Medical Apparatus & Instrument Industry Co Ltd

Guangzhou Shanshan Medical Apparatus & Instrument Industry Co Ltd, based in Guangzhou, China, holds over 1,500 patents related to infertility treatment devices, with approximately 200 patents in progress. The company focuses on innovations in ergonomic designs and advanced material technologies, aiming to improve fertility treatment outcomes and patient safety.

Fertility Basics Inc

Fertility Basics Inc., headquartered in San Diego, California, has filed over 1,200 patents in the infertility treatment devices sector, with around 150 patents currently in progress. The company specialises in smart fertility monitoring systems and automated treatment technologies, enhancing patient comfort and care efficacy through strategic patent filings.

Other key players in the industry include Vertex Pharma, Genentech Inc., and Merck Sharp & Dohme.

Key Questions Answered in the Global Infertility Treatment Devices Patent Landscape Report

• What are infertility treatment devices, and why are they important in reproductive healthcare?
• What is the current state of the global patent landscape for infertility treatment devices?
• Which companies are leading patent filings in the infertility treatment devices industry?
• What are the key drivers of patent activity in infertility treatment technologies?
• How do innovations in ergonomic design and material composition impact infertility treatment devices?
• What role does regulatory compliance play in the development of infertility treatment devices?
• Which regions are most active in patent filings for infertility treatment devices, and why?
• How are patents for smart systems and automation influencing the infertility treatment landscape?
• What future trends are anticipated in the infertility treatment devices patent landscape?
• How do jurisdictional differences affect the patent landscape for infertility treatment devices?
• What challenges do companies face in securing patents for infertility treatment technologies?
• How are patents for devices used in fertility clinics different from those for research institutes?
• What impact does sustainability have on patent filings in the infertility treatment devices industry?
• How is the competitive landscape in the infertility treatment devices industry shaped by patent activities?

Reasons to Purchase this Report

This report offers an in-depth analysis of the patent landscape, covering key trends, technological advancements, and regional insights. It provides detailed segmentation and highlights areas of significant innovation and activity. By examining leading companies' strategies and patent portfolios, the report elucidates competitive dynamics and emerging opportunities. Stakeholders will gain valuable information for strategic decision-making, ensuring they stay ahead in the evolving industry. This comprehensive coverage makes it an essential resource for understanding the industry's future direction."
"Global Wound Therapy Devices Patent Landscape Report 2024

Global Wound Therapy Devices Industry Size

The global wound therapy devices market size was valued at USD 1.6 billion in 2023. The market is anticipated to grow at a CAGR of 4.2% during the forecast period 2024-2032 to reach a value of USD 2.3 billion by 2032. The patent landscape for wound therapy devices is robust, with the United States leading in filings. Over 2,000 patents focus on innovations in NPWT and HBOT systems, targeting enhanced patient comfort and treatment efficiency.

Patent Landscape Report Coverage

This report offers a comprehensive analysis of the global wound therapy devices patent landscape. It delves into patent trends, key innovations, and emerging technologies within the field of wound therapy devices. The report examines patent filings, patent grants, and leading companies, highlighting the strategic advancements and innovations that are shaping the future of wound therapy technology. It serves as an essential resource for stakeholders seeking insights into the intellectual property dynamics and competitive landscape of the wound therapy devices industry.

Global Wound Therapy Devices Patent Outlook

• The wound therapy devices patent landscape is driven by innovations in negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT) systems, along with the integration of smart technologies. Over 5,000 patents have been filed globally, emphasizing advanced designs and enhanced patient comfort.
• Key companies such as Smith & Nephew Plc and Mölnlycke Health Care AB lead the patent landscape, holding over 1,300 and 1,000 patents, respectively. These companies focus on advanced wound dressings and smart system integrations, underscoring their commitment to innovation and leadership in wound care technology.
• In the United States, over 2,000 patents emphasize advanced wound care technologies. European patents, particularly in Germany and the UK, focus on device safety and efficiency, driven by regulatory standards. The Asia Pacific region, led by China and Japan, prioritises cost-effective and scalable solutions with over 1,200 patents filed.

Wound Therapy Devices Introduction

Wound therapy devices are crucial in managing and healing various types of wounds, including acute and chronic wounds. These devices, such as negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT) systems, are designed to promote faster healing, reduce infection risk, and improve patient outcomes. The patent landscape for wound therapy devices reflects significant innovation driven by the need for more effective treatment modalities, enhanced patient safety, and the integration of advanced technologies.

• Patent activity in NPWT devices focuses on innovations that improve suction efficiency and dressing compatibility. Over 1,000 patents have been filed in the past decade, with recent filings emphasizing sensor integration for better wound monitoring and patient comfort.
• HBOT devices have seen a surge in patents aimed at enhancing chamber design and oxygen delivery systems. Historically, around 800 patents have been filed, with new patents focusing on portable and user-friendly models that increase accessibility and patient compliance.
• The incorporation of smart technologies in wound therapy devices is a key patent driver, with approximately 600 patents filed focusing on AI-driven monitoring and automated pressure adjustment systems. Future innovations are expected to enhance device automation and personalised treatment protocols.

These drivers foster a dynamic patent landscape, promoting cutting-edge innovations in wound care technology, which enhance treatment efficacy, patient safety, and device adoption in clinical practice.

Global Wound Therapy Devices Patent Segmentation Analysis

The report provides an in-depth analysis of the patents in this field by the following segmentation –

Analysis by Product

• Negative Pressure Wound Therapy (NPWT) Devices
• Oxygen and Hyperbaric Oxygen Equipment
• Electric Stimulation Devices
• Pressure Relief Devices
• Others

The patent segmentation in the wound therapy devices industry includes NPWT devices, oxygen and hyperbaric oxygen equipment, electric stimulation devices, pressure relief devices, and Others. Among these, NPWT devices lead the patent landscape with over 1,500 patents granted historically and more than 200 new filings in the last year. This leadership is driven by innovations in system efficiency and sensor integration for real-time monitoring. Future growth is expected as advancements focus on enhancing patient comfort and dev